RxDoctor Payments Data

Sabrina Budden-Wright

Psychiatric/Mental Health · Brooklyn, NYNPI 1376205856

Payments from drug & device makers

$2,648in general payments, 2019–2025

Across 167 payments — averaging $15.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$419
  • Lundbeck LLC$288
  • AbbVie$279
  • Alkermes, Inc.$260
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$245
  • Teva Pharmaceuticals USA, Inc.$222
  • plus $935 from 14 others

What the payments were for

  • Food & beverage$2,648100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,648 in reported general payments places this provider in the 80th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York

Medicare billing

Part B allowed, 2024
$11,413
Medicare patients
42
Services billed
115

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole13$37,859
VraylarCariprazine Hcl19$28,899
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl20$3,323
Aripiprazole65$1,184
Doxepin Hcl21$1,156
Atomoxetine Hcl15$1,119
Venlafaxine Hcl ErVenlafaxine Hcl27$1,115
Quetiapine Fumarate74$962
Bupropion XlBupropion Hcl62$956
Hydroxyzine Hcl47$785
Gabapentin66$635
Duloxetine Hcl39$632
Buspirone Hcl69$522
Ziprasidone Hcl14$504
Oxcarbazepine17$496

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$419$37,85913 claims
AbbVieVraylar$279$28,89919 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →